Molecular and Immunological Biomarkers in Cervical Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Endocrinology and Metabolism".
Deadline for manuscript submissions: 20 December 2025 | Viewed by 314
Special Issue Editors
Interests: immune response; biomarkers in gynecological cancers; microRNAs in cancer and chronic diseases; non-coding RNAs; cervical cancer; endometriosis; women's health
Special Issue Information
Dear Colleagues,
Cervical cancer remains a major global health concern, significantly impacting women's health and contributing to substantial healthcare costs. Addressing this challenging carcinoma requires a detailed exploration of the molecular and immunological mechanisms underlying its development, progression, and treatment responses. The continuous identification and validation of biomarkers are crucial for advancing diagnostic accuracy, improving prognostic assessments, and identifying new therapeutic targets.
The immune system plays a critical role in the onset and progression of cervical cancer, especially given its strong association with persistent human papillomavirus infection. Understanding the immunological dynamics within the tumor microenvironment, including immune evasion mechanisms and the modulation of immune responses, is essential for the development of effective immunotherapies and personalized treatments. Recent advancements in immunology, coupled with molecular biology and omics technologies, have provided valuable insights into these processes, creating new opportunities to improve patient outcomes.
Therefore, this Special Issue aims to highlight research focused on the molecular and immunological aspects of cervical cancer, with a particular emphasis on the discovery and application of biomarkers that drive advancements in diagnosis, prognosis, and therapy. We welcome contributions exploring the intricate interplay between molecular pathways and immune responses, as well as innovative diagnostic tools, therapeutic strategies, translational approaches, systematic reviews, and meta-analyses. Interdisciplinary collaborations that deepen our understanding of cervical cancer and contribute to its improved management are especially encouraged.
We look forward to your valuable contributions.
Dr. Janaina Cristiana de Oliveira Crispim
Prof. Dr. Ricardo Ney Oliveira Cobucci
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cervical cancer
- molecular biomarkers
- immunological biomarkers
- human papillomavirus (HPV)
- tumor microenvironment
- immune responses
- immunotherapy
- diagnostic biomarkers
- prognostic biomarkers
- therapeutic targets
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
